PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsinborn urea cycle disorders
MeSH D056806 - inborn urea cycle disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000592:Inborn errors amino acid metabolism
3 Companies
2 Drugs
$
Success rate
D020739:Metabolic brain diseases inborn
0 Companies
0 Drugs
Success rate
D056806: 
Inborn urea cycle disorders
1 Company
1 Drug
$
Success rate
D020159:Citrullinemia
1 Company
1 Drug
$
Success rate
D020162:Hyperargininemia
0 Companies
0 Drugs
Success rate
D020163:Ornithine carbamoyltransferase deficiency disease
1 Company
1 Drug
$
Success rate
D020165:Carbamoyl-phosphate synthase i deficiency disease
2 Companies
1 Drug
$
Success rate
D056807:Argininosuccinic aciduria
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Immedica PharmaGlycerol phenylbutyrate Ravicti  2015-11-26   
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
75%
3/4
Phase 3
50%
2/4
Approved: 1Overall Success rate: 38%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use